Operationalize PFAS Compliance Across Your Product Portfolio

IntegrityNext Product and Material Compliance enables:

  • Scalable supplier evidence collection across the portfolio
  • Structured capture of declarations and test results
  • Consistent evaluation against PFAS thresholds
  • Audit-ready documentation for products and compliance decisions

 

Book a demo

Why PFAS Matters

The EU s proposed PFAS universal restriction introduces a structural definition (not a substance list), three concurrent concentration limits, and complex derogation pathways by sector.


PFAS is not managed like classic restricted substance programs. It forces a different compliance approach.

Structural definition, not a list of substances

PFAS is defined by molecular structure and covers 10,000+ substances. You cannot rely on checking a fixed list of CAS numbers. For many suppliers, reliable confirmation requires analytical testing, verified composition knowledge, or a declaration approach that explicitly handles uncertainty.

Three thresholds apply at the same time

The proposed restriction applies three limits at once:

  • Any single PFAS: 25 ppb
  • Sum of measurable PFAS: 250 ppb
  • Total fluorine: 50 ppm (capturing polymers such as PTFE)

The three limits are evaluated together. Companies need to demonstrate compliance using the applicable test results and supporting evidence, including clarification of fluorine sources where relevant.

Derogations are a matrix, not a checkbox

The proposal includes 75+ sector derogations with different durations (none / five years / twelve years / unlimited categories). Determining applicability depends on sector and use case. Operationally, this is not a simple “exempt” flag. It requires structured selection, evidence capture, and lifecycle tracking and to monitor site-related PFAS emissions requirements, which may tighten over time depending on activity and permitting context.

Cross-regulation overlap is unavoidable

Some PFAS are already restricted under existing regimes such as POPs and specific REACH restrictions. Companies need a single data foundation that reduces duplicate supplier requests and supports evidence reuse across overlapping obligations.

PFAS Regulatory Timeline

Status (as of May 2026): The PFAS universal restriction remains proposed and is progressing through the EU restriction process. The public consultation phase has closed (May 25). SEAC is now reviewing consultation input and preparing its final opinion. The SEAC opinion, together with the RAC final opinion, will inform the Commission’s next steps toward drafting and decision-making.

Key Milestones to Plan Around

Late May 2026

Proposal is still under evaluation in the EU process. Companies should treat this period as the time to establish PFAS data collection standards, supplier workflows, and internal governance for analytical results.

2026 (second half)

Consultation feedback and finalization of opinions are expected to progress, which may adjust derogation details and sector scoping.

2027 to 2028

Likely window for Commission drafting and political decision-making. This is typically the most practical “build and prepare” window for systems, supplier enablement, and portfolio baselining.

Around 2029 (earliest realistic):

If adopted, enforcement could begin after a transition period. This is the first plausible compliance deadline for sectors without derogations.

Around 2034 to 2035

Typical expiry window for five-year derogations, where applicable.

Around 2041 to 2042

Typical expiry window for twelve-year derogations, often relevant to semiconductors, electronics, and medical devices.

What This Means Operationally

The long lead time is not a reason to defer action. It is the window companies need to establish a defensible data model, supplier workflows, and governance for testing and declarations.

Core Challenges for Companies

PFAS compliance breaks down in predictable ways, especially when programs are built around static substance lists.

A “PFAS free” statement is hard to substantiate

A “PFAS free” statement is hard to substantiate

Suppliers often cannot verify PFAS absence through a list-based approach. Without clear declaration logic, teams receive inconsistent answers, or overconfident responses with weak evidence.

Analytical results are stored, but not operationalized

Analytical results are stored, but not operationalized

PFAS requires structured capture of three different measures with different units. When results live as PDFs and attachments without consistent fields, compliance status becomes difficult to reproduce and explain.

Derogation applicability is difficult to determine and maintain

Derogation applicability is difficult to determine and maintain

Derogations are time-bound and sector specific. Even when a derogation exists, companies must track reliance, scope, duration, and evidence requirements. Otherwise, products appear compliant until the day they are not.

Supplier outreach does not scale in manual workflows

Supplier outreach does not scale in manual workflows

PFAS data collection involves large volumes of suppliers, reminders, follow-ups, and resolution of “unknown” responses. Email-based processes are slow, hard to audit, and create blind spots.

Audit defense requires a full evidence trail

Audit defense requires a full evidence trail

PFAS decisions will be scrutinized. Teams need traceable records of what was asked, what was received, how thresholds were evaluated, and which items rely on derogations.

Build a Scalable PFAS Compliance Foundation

Prepare for the EU PFAS restriction with a structured, evidence-based approach. Standardize supplier data collection and capture analytical test results in consistent formats. Ensure reliable, audit-ready compliance across your entire product portfolio.

Book a demo

Make PFAS Compliance Scalable

Standardize how you manage PFAS requirements across your portfolio with a unified, repeatable workflow, replacing fragmented and manual approaches.

  • End-to-end workflow from portfolio screening to evidence collection and compliance evaluation
  • Consistent processes across products, materials, and suppliers

Eliminate Duplicate Work Across Regulations

Collect product data and supplier evidence once and reuse it across multiple substance requirements, reducing supplier fatigue and internal rework.

  • Single data collection with reuse across multiple regulations  
  • Centralized management of declarations and analytical results  

Gain Clear, Product-Level Visibility

Understand PFAS compliance status at a glance with structured, comparable data across your portfolio.

  • Standardized data fields for consistent supplier input  
  • Automated evaluation across all three PFAS thresholds  
  • Clear status flags for compliant, at risk, or missing data  

Stay Flexible in a Changing Regulatory Landscape

Adapt quickly to evolving PFAS definitions and thresholds without redesigning your processes.

  • Multi-regulation-ready workflow design
  • Configurable evidence standards, including handling of unknown

Ensure Audit-Ready Traceability

Maintain a complete, defensible record of all compliance activities to confidently respond to audits and customer requests.  

  • Traceable supplier requests and responses  
  • Centralized evidence and documentation management  
  • Full audit trail with documented evaluation rationale

How You Benefit

Move from PFAS uncertainty to a defensible evidence baseline

Create consistent supplier expectations and an evidence trail that reflects the structural nature of PFAS, including clear handling of incomplete information.

Reduce risk with consistent evaluation of all three PFAS limits

Ensure PFAS status is determined the same way across products, teams, and regions, with visibility into which threshold drives risk.

Prioritize effort by focusing on high-risk products first

Screen and segment the portfolio so supplier outreach and testing efforts are directed to where PFAS use is most likely, instead of treating every product the same.

Support customer and market expectations for PFAS-free products

Enable credible substantiation for “PFAS-free” or “PFAS-reduced” claims where the business chooses to pursue them, using supplier-backed evidence and documented decision rules.

Accelerate substitution planning by identifying where PFAS is driving dependency

Surface which materials, processes, or product families rely on PFAS so R and D and procurement can target alternatives and track progress over time, even before legal deadlines apply.

Be ready for scrutiny with audit-ready documentation on demand

Respond faster to audits and customer requests with traceable inputs, supporting documents, and reproducible conclusions.

Build a PFAS-ready foundation that scales as rules and expectations mature

Establish repeatable processes and reusable evidence so PFAS does not become a recurring reinvention for each product line and supplier group.

Turn PFAS Complexity into Operational Clarity

Manage PFAS requirements with one unified and scalable workflow. Track supplier declarations, analytical results, and compliance status in a single system. Stay ready for evolving regulations with clear visibility and traceable documentation.

Book a demo

Which Industries are Affected by PFAS

PFAS impacts industries differently because derogations and material realities differ by sector.

High-volume Consumer And Packaging Portfolios

These portfolios often have high SKU counts and frequent material changes, which makes PFAS evidence collection an operational challenge. The key need is scalable supplier outreach, consistent capture of analytical results, and clear escalation paths for unknown responses.

Electronics, Semiconductors, PCBs, Wires/Cables

Often covered by longer derogations, but complex product structures and deep supply chains make data collection difficult. Priorities include component-level evidence, derogation tracking, and substitution planning over multi-year horizons.

Industrial Manufacturing And Coatings

Exposure varies by surface treatments, coatings, seals, and fluids. The challenge is mapping PFAS use across materials and processes that are often documented inconsistently.

Medical Devices And Regulated Applications

Longer timelines may apply, but evidence expectations are high. Traceability and documentation quality are critical, along with a clear method for handling “unknown” declarations responsibly.

Book a Demo

Ready to Streamline Product Compliance Across Your Supply Chain?

Speak with our team and learn how IntegrityNext can help you automate compliance workflows, collect validated supplier data, and stay ahead of evolving product regulations.

  • Manage PFAS, REACH, RoHS, Conflict Minerals, and EUDR in one platform

  • Detect material and regulatory risks across all supplier tiers

  • Maintain audit-ready documentation and meet customer expectations

FAQ: EU PFAS Compliance

Is the EU PFAS universal restriction already law?

No. It is currently proposed and progressing through the EU process. That said, preparation is practical because the data collection and supplier enablement effort is significant, and PPWR introduces identical limits for food-contact packaging from August 2026.

Why can’t we manage PFAS like REACH SVHC or RoHS?

PFAS is defined by chemical structure, not a fixed list of substances. In many cases, you need analytical results or deeper composition evidence rather than a simple “contains/does not contain” list check.

What analytical data do we need to collect for PFAS?

The proposed restriction applies three limits simultaneously: individual PFAS concentration (25 ppb), sum of measurable PFAS (250 ppb), and total fluorine (50 ppm). Capturing these as structured, comparable fields is essential for consistent evaluation.

How do derogations work, and why do they matter operationally?

Derogations are sector- and use-case-specific grace periods (often none, five years, or twelve years). Products relying on derogations require tracking because compliance may expire—creating redesign, substitution, or supplier remediation needs.

How should we prepare while the restriction is still proposed?

Focus on building a PFAS-ready evidence baseline. Standardize supplier declarations for presence and uncertainty, define when analytical testing is required, and ensure results can be captured consistently across the three threshold measures. This reduces lead time when final scope and derogation details are confirmed.

Why prepare now if the PFAS restriction is still proposed?

Because PFAS evidence collection takes time. Starting early lets you prioritize high-risk products, standardize supplier declarations and testing expectations, and build an audit-ready baseline that can adapt once final scope, transition periods, and derogations are confirmed. It also helps address growing requirements outside the EU, including US state-level PFAS restrictions in certain product categories and customer requests for PFAS-free products.